Rheumatoid Arthritis
Conditions
Interventions
Self-monitoring of disease activity combined with self initiated care
Sponsors
None
Eligibility
Inclusion criteria
Inclusion criteria: • Diagnosed with RA by a rheumatologist • Disease duration of at least 2 years • Low disease activity or remission (DAS28 < 3,2) at moment of inclusion • Taking a disease-modifying anti-rheumatic drug (DMARD) • Own a mobile device with an Android or iOS operating system (implying mobile phone literacy) • At least 18 years old • Able to read and speak Dutch
Exclusion criteria
Exclusion criteria: • Medication change: start or stop of a DMARD (biologicals, or conventional DMARDS*) in the last 6 months. • Is taking part in another intervention study * Methotrexate, cyclosporine, cyclophosphamide, gold injections, hydroxychloroquine, leflunomide, mycophenolate, sulfasalazine, corticosteroids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DAS 28 & Number of outpatient clinic visits | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction (10-point Likert scale), patient empowerment (Effective consumer scale), Disease activity (Rapid 3), Treatment satisfaction (TSQM-9), medication adherence (CQR5), Healthcare Participation (WPAI), Overall Costs (Tic-P), Adherence (Questionnaire completion rates), Qualitative Data, App usability (System Usability Scale) | — |
Contacts
Public ContactBart Seppen
Reade
Outcome results
None listed